Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eliana S. Armstrong
Observed names:
Armstrong, Eliana,
Armstrong, Eliana S.,
E.S. Armstrong,
Eliana Armstrong,
Eliana S Armstrong
Institution:
Achaogen (United States)
Observed institutions:
Merck & Co., Inc., Rahway, NJ, USA (United States),
Paratek Pharmaceuticals (United States),
Biosearch Technologies (United States),
Achaogen (United States),
Université de Montréal
OpenAlex ID:
A5061519281
Synthesis and Spectrum of the Neoglycoside ACHN-490
2010
·
James B. Aggen
, Eliana S. Armstrong
, et al.
·
Antimicrobial Agents and Chemotherapy
·
250
Detection of Methyltransferases Conferring High-Level Resistance to Aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America
2008
·
Thomas R. Fritsche
, Mariana Castanheira
, et al.
·
Antimicrobial Agents and Chemotherapy
·
145
ACHN-490, a Neoglycoside with Potent In Vitro Activity against Multidrug-Resistant Klebsiella pneumoniae Isolates
2009
·
Andrea Endimiani
, Kristine M. Hujer
, et al.
·
Antimicrobial Agents and Chemotherapy
·
115
Combating evolution with intelligent design: the neoglycoside ACHN-490
2010
·
Eliana S Armstrong
, George H Miller
·
Current Opinion in Microbiology
·
107
A Multicenter, Randomized, Double-Blind, Phase 2 Study of the Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis
2018
·
Lynn E. Connolly
, Valerie Riddle
, et al.
·
Antimicrobial Agents and Chemotherapy
·
90
Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa
2019
·
Kevin M. Krause
, Cat M. Haglund
, et al.
·
Antimicrobial Agents and Chemotherapy
·
69
PDF
Aminoglycosides
2011
·
Eliana S. Armstrong
, Corwin F. Kostrub
, et al.
·
Springer eBooks
·
33
BTI1, an Azoreductase with pH-Dependent Substrate Specificity
2011
·
Hans E. Johansson
, Mary K. Johansson
, et al.
·
Applied and Environmental Microbiology
·
31
Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals
2011
·
Fred C. Tenover
, Isabella Tickler
, et al.
·
International Journal of Antimicrobial Agents
·
29
Toxicity Modulation, Resistance Enzyme Evasion, and A-Site X-ray Structure of Broad-Spectrum Antibacterial Neomycin Analogs
2014
·
Juan Pablo Maianti
, Hiroki Kanazawa
, et al.
·
ACS Chemical Biology
·
24
Hybrid Aminoglycoside Antibiotics via Tsuji Palladium-Catalyzed Allylic Deoxygenation
2011
·
Stephen Hanessian
, Juan Pablo Maianti
, et al.
·
Organic Letters
·
22
Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa
2011
·
Glenn A. Pankuch
, Gengrong Lin
, et al.
·
Antimicrobial Agents and Chemotherapy
·
22
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin Analogue
2011
·
Stephen Hanessian
, Alexandre Giguère
, et al.
·
ACS Medicinal Chemistry Letters
·
20
In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study
2015
·
Eliana S. Armstrong
, David J. Farrell
, et al.
·
Antimicrobial Agents and Chemotherapy
·
17
PDF
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
2016
·
Eliana S. Armstrong
, Janelle A. Mikulca
, et al.
·
BMC Infectious Diseases
·
7
PDF
1377. Omadacycline In Vitro Activity Against a Molecularly Characterized Collection of Clinical Isolates with Known Tetracycline Resistance Mechanisms
2018
·
Rodrigo E Mendes
, Mariana Castanheira
, et al.
·
Open Forum Infectious Diseases
·
2
PDF
1364. Efficacy of Omadacycline Against Molecularly Characterized Gram-Positive and Gram-Negative Pathogens Causing Infections in the Phase 3 CABP and ABSSSI Clinical Trials
2018
·
Rodrigo E Mendes
, Mariana Castanheira
, et al.
·
Open Forum Infectious Diseases
·
1
PDF
Analysis of the Microbiological data from the Omadacycline (OMC) Phase 3 Community-Acquired Bacterial Pneumoniae (CABP) trial: The OPTIC study
2017
·
Eliana Armstrong
, Evan Tzanis
, et al.
·
Open Forum Infectious Diseases
·
1
Clinical Outcomes of Ceftolozane/Tazobactam Treatment of Piperacillin/Tazobactam and Ceftazidime Non-Susceptible Pathogens From Two Phase 3 Trials and Associated in Vitro Activity
2015
·
Myra Popejoy
, Eliana Armstrong
, et al.
·
Open Forum Infectious Diseases
·
1
CCDC 1834955: Experimental Crystal Structure Determination
2018
·
Maianti, Juan Pablo
, Kanazawa, Hiroki
, et al.
·
The Cambridge Structural Database
CCDC 1834956: Experimental Crystal Structure Determination
2018
·
Maianti, Juan Pablo
, Kanazawa, Hiroki
, et al.
·
The Cambridge Structural Database
Additional file 1: of Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
2016
·
Armstrong, Eliana
, Mikulca, Janelle
, et al.
·
Figshare
Efficacy of Ceftolozane/Tazobactam Versus Levofloxacin in the Treatment of Complicated Pyelonephritis: Results From the Phase 3 ASPECT-cUTI Trial
2015
·
Daniel Cloutier
, Loren Miller
, et al.
·
Open Forum Infectious Diseases
Crystal structure of the bacterial ribosomal decoding site in complex with synthetic aminoglycoside with F-HABA group
2014
·
J.P. Maianti
, H. Kanazawa
, et al.
·
Worldwide Protein Data Bank
The BTI1 Azoreductase Colorimetric and Fluorometric Reporter System
2009
·
Hans E. Johansson
, Mary K. Johansson
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
27
Citation count:
986
H-index:
14
I10-index:
14
Year
Topic
Type
